Therefore, establishing an effective detection method for plasma DNMT1, which can convert single baseline static prediction into an early dynamic assessment during diagnosis and treatment, is of great importance for the prognosis and survival of breast cancer patients. This evidence concerns the gene DNMT1 and breast cancer.